ENTA Stock Analysis: Buy, Sell, or Hold?
ENTA - Enanta Pharmaceuticals, Inc
$15.11
0.34 (2.30%)
▲
5d:
+12.34%
30d:
+25.6%
90d:
+16.5%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ENTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ENTA is 7.9% above its trading range ($14.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ENTA is 7.9% above its trading range ($14.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ENTA is currently trading at $15.11, which is considered extended relative to its 30-day fair value range of $11.62 to $14.01.
Technical Outlook: Technically, ENTA is showing sideways momentum. The price is approaching resistance at $13.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ENTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.14 (+33.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENTA is showing sideways momentum. The price is approaching resistance at $13.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ENTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.14 (+33.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.62 -
$14.01
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
Protect Your Profits
Holding ENTA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.9% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.3% below Wall St target ($20.14)
- CAUTION: Extended 7.9% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$11.62 -
$14.01
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.25
(8.3%)
Support & Resistance Levels
Support Level
$10.86
Resistance Level
$13.85
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.73
Wall Street Target
$20.14
(+33.3%)
Revenue Growth (YoY)
15.0%
Earnings Growth (YoY)
-66.2%
Profit Margin
-89.6%
Share & Embed Analysis
Last updated: July 02, 2026 9:40 PM ET
Data refreshes hourly during market hours. Next update: 10:40 PM
Data refreshes hourly during market hours. Next update: 10:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
Advanced ENTA Option Strategies
Professional options setups generated by AI based on today's ENTA price and gamma walls.
